SCHEMBL30823329

SCHEMBL30823329

CC(C)(C)[Si](C)(C)OCCC/C=C/C(=O)OCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.48
MAPT P10636 1/20 0.46
LMNA P02545 1/20 0.46
AKR1B10 O60218 3/20 0.43
AKR1B1 P15121 3/20 0.43
CA12 O43570 2/20 0.43
CA4 P22748 2/20 0.43
CA6 P23280 2/20 0.43
CA5A P35218 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
CA14 Q9ULX7 2/20 0.43
CA5B Q9Y2D0 2/20 0.43
TTR P02766 1/20 0.43
ALDH1A1 P00352 4/20 0.42
POLB P06746 1/20 0.42
BTN3A1 O00481 1/20 0.39
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2631175 0.81 MAPT (0.55) HCAR2MAPTCA12CA7CA9
SCHEMBL21959487 0.79 ALDH1A1 (0.37) LMNAALDH1A1BTN3A1L3MBTL1CYP3A4
SCHEMBL7308118 0.79 ALDH1A1 (0.46) LMNAALDH1A1BTN3A1L3MBTL1CYP3A4
SCHEMBL11034024 0.78 HCAR2 (0.56) HCAR2MAPTLMNAAKR1B10AKR1B1
SCHEMBL1879665 0.78 HCAR2 (0.59) HCAR2MAPTLMNAAKR1B10AKR1B1
SCHEMBL1937865 0.76 DUT (0.35) HCAR2MAPTLMNATSHRTDP1
SCHEMBL1937866 0.76 DUT (0.35) HCAR2MAPTLMNATSHRTDP1
SCHEMBL14871736 0.76 HCAR2 (0.56) HCAR2MAPTLMNAAKR1B10AKR1B1
SCHEMBL29196901 0.76 HCAR2 (0.56) HCAR2MAPTLMNAAKR1B10AKR1B1
SCHEMBL1895297 0.76 HTT (0.58) MAPTLMNAL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577526-A1 VHH ANTIBODY CONJUGATES Abdera Therapeutics Inc. (US) 2025-07-02 EP disclosed
WO-2024044549-A1 VHH ANTIBODY CONJUGATES Abdera Therapeutics Inc. (US) 2024-02-29 WO disclosed